EMIT Imaging, Inc

EMIT Imaging, Inc, based in South Boston, MA, specializes in Cryo-Fluorescence Tomography (CFT), a cutting-edge 3D imaging technique for studying drug distribution and protein expression in whole animals. Their innovative imaging platform, Xerra™, provides high resolution and sensitivity, facilitating advancements in biological and drug research.

CFT offered by EMIT Imaging bridges the gap between cellular microscopy and whole-body imaging techniques like MRI, PET, and SPECT. By offering a comprehensive view of tissues and aiding in evaluating diseases and treatments, CFT expands preclinical imaging capabilities to guide technologies such as pathology and proteomics.

With a focus on application areas like Drug Discovery & Delivery, Oncology & Immunotherapy, Gene & Cell Therapy, and Neuroscience, EMIT Imaging's services include fee-for-service research conducted in their state-of-the-art labs in Boston, MA, and Baltimore, MD. Their technology allows for whole-body detection and visualization, making them a valuable asset in various research fields.

Generated from the website content